- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: July 2013
- Public Summary Document (PSD) July 2013 PBAC Meeting - PDF
Erlotinib – July 2013
Erlotinib, tablets, 25 mg, 100 mg, 150 mg (as hydrochloride), Tarceva®
Last updated
8 November 2023